{"id":466870,"date":"2026-05-03T20:09:20","date_gmt":"2026-05-03T20:09:20","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/466870\/"},"modified":"2026-05-03T20:09:20","modified_gmt":"2026-05-03T20:09:20","slug":"investors-back-glanbia-as-a-rare-food-company-that-might-benefit-from-people-eating-less-the-irish-times","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/466870\/","title":{"rendered":"Investors back Glanbia as a rare food company that might benefit from people eating less \u2013 The Irish Times"},"content":{"rendered":"<p class=\"c-paragraph paywall \">Shares in <a href=\"https:\/\/www.irishtimes.com\/tags\/glanbia\/\" target=\"_self\" rel=\"nofollow noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/glanbia\/\">Glanbia<\/a> jumped 9 per cent on Wednesday after a strong trading update, though the more intriguing narrative sits beyond whey protein and into the slow-burn impact of weight-loss drugs. <\/p>\n<p class=\"c-paragraph paywall \">GLP-1 therapies suppress appetite, and exploding demand for them has left much of the food industry scanning for casualties. <\/p>\n<p class=\"c-paragraph paywall \">However, <a href=\"https:\/\/www.irishtimes.com\/tags\/barclays\/\" target=\"_self\" rel=\"nofollow noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/barclays\/\">Barclays<\/a> analysts think Glanbia may instead be a beneficiary of sorts.<\/p>\n<p class=\"c-paragraph paywall \">Growth in the first quarter came from volumes rather than pricing, with obvious strength in performance nutrition and <a href=\"https:\/\/www.irishtimes.com\/tags\/health-wellness\/\" target=\"_self\" rel=\"nofollow noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/health-wellness\/\">health<\/a> and nutrition. In other words, consumers are buying a lot more, with that demand being concentrated in protein, <a href=\"https:\/\/www.irishtimes.com\/tags\/fitness\/\" target=\"_self\" rel=\"nofollow noopener\" title=\"https:\/\/www.irishtimes.com\/tags\/fitness\/\">fitness<\/a> and \u201cactive lifestyle\u201d products.<\/p>\n<p class=\"c-paragraph paywall \">That is the supposed GLP-1 twist. If people eat less overall, they may also become more selective, tilting towards protein-rich and functional foods and away from conventional snacking. <\/p>\n<p class=\"c-paragraph paywall \">Glanbia\u2019s flagship Optimum Nutrition brand sits comfortably in that niche. Any caveats? There are a few. <\/p>\n<p class=\"c-paragraph paywall \">Glanbia\u2019s earnings beat may have been flattered by promotional demand in January and February \u2013 \u201cNew Year, New You\u201d, and all that. <\/p>\n<p class=\"c-paragraph paywall \">Some investors also question whether there was a pre-buy effect in advance of April\u2019s price increases. Barclays is positive on that front, saying management commentary suggested that any pre-buy impact was \u201climited, pointing to a clear underlying beat\u201d. <\/p>\n<p class=\"c-paragraph paywall \">Still, that won\u2019t become clear for some time, with April\u2019s price rises set to be a better test of underlying demand.<\/p>\n<p class=\"c-paragraph paywall \">Nevertheless, with the shares already up 35 per cent in 2026, investors are backing Glanbia as a rare food company that might benefit from people eating less.<\/p>\n","protected":false},"excerpt":{"rendered":"Shares in Glanbia jumped 9 per cent on Wednesday after a strong trading update, though the more intriguing&hellip;\n","protected":false},"author":2,"featured_media":466871,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73],"tags":[31165,79,18,525,181,6693,19,17],"class_list":{"0":"post-466870","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business","8":"tag-barclays","9":"tag-business","10":"tag-eire","11":"tag-fitness","12":"tag-glanbia","13":"tag-health-wellness","14":"tag-ie","15":"tag-ireland"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116512461058574661","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/466870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=466870"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/466870\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/466871"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=466870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=466870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=466870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}